Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC).
Several biological factors have emerged as potential drivers of PASC pathology. Some …

Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a
global population of more than 35 million people living with HIV, there is intense interest in …

COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

Background The biological processes associated with postacute sequelae of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) are unknown. Methods …

BACKGROUND The presence and reactivation of chronic viral infections, such as EBV, CMV,
and HIV, have been proposed as potential contributors to long COVID (LC), but studies in …

… Henrich had full access to all of the data in the study and takes responsibility for the integrity
… Critical revision of the article for important intellectual content: TJ Henrich, FM Marty, MN …

Cellular HIV-1 reservoirs that persist despite antiretroviral treatment are incompletely defined.
We show that during suppressive antiretroviral therapy, CD4 + T memory stem cells (T …

Studies have demonstrated that at least 20% of individuals infected with SARS-CoV-2 remain
asymptomatic 1 , 2 , 3 – 4 . Although most global efforts have focused on severe illness in …

We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell
responses, soluble markers of inflammation, and antibody levels and neutralization capacity …

Post-acute sequelae of COVID-19 (PASC, "Long COVID") pose a significant global health
challenge. The pathophysiology is unknown, and no effective treatments have been found to …